Growth failure in bronchopulmonary dysplasia: elevated metabolic rates and pulmonary mechanics

S I Kurzner1, M Garg, D B Bautista

  • 1Division of Neonatology and Pediatric Pulmonology, Childrens Hospital of Los Angeles, CA 90027.

Insights

Infants with bronchopulmonary dysplasia (BPD) experiencing growth failure have significantly higher resting oxygen consumption (Vo2). This elevated Vo2, linked to increased work of breathing, suggests complex metabolic demands contribute to poor growth in BPD infants.

Area of Science:

  • Pediatrics
  • Neonatology
  • Respiratory Medicine

Background:

  • Growth failure is a significant complication in infants diagnosed with bronchopulmonary dysplasia (BPD).
  • The underlying causes of growth failure in BPD infants remain incompletely understood.
  • This study focuses on BPD infants without other confounding medical conditions affecting growth.

Purpose of the Study:

  • To investigate the metabolic demands, specifically resting oxygen consumption (Vo2), in infants with BPD and growth failure.
  • To explore the relationship between Vo2, pulmonary mechanics, and growth parameters in BPD.
  • To identify potential mechanisms contributing to growth failure in BPD.

Main Methods:

  • Studied 13 infants with BPD at 6 months' corrected age, categorized by growth failure (height/weight <10th percentile).
  • Measured resting oxygen consumption (Vo2), Pao2, airway resistance, specific airway conductance, and dynamic pulmonary compliance (Cdyn) using body plethysmography.
  • Compared measurements between BPD infants with and without growth failure, and with healthy controls.

Main Results:

  • Infants with BPD and growth failure exhibited markedly elevated Vo2 compared to controls and BPD infants with normal growth.
  • A significant inverse correlation was observed between Vo2 and body weight in BPD infants.
  • While Vo2 was inversely related to dynamic pulmonary compliance (Cdyn), the work of breathing only partially accounted for the increased metabolic demands.

Conclusions:

  • Elevated metabolic demands, indicated by increased Vo2, are associated with growth failure in infants with BPD.
  • Increased work of breathing contributes to these heightened metabolic demands, but other factors likely play a role.
  • Further research is needed to elucidate all mechanisms driving metabolic expenditure and growth failure in BPD.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...